Armata Pharmaceuticals
$7.51
6
+$0.17+2.32% Friday 19:59
Statistics
Day High
7.99
Day Low
7.06
52W High
14.69
52W Low
1.84
Volume
77,900
Avg. Volume
-
Mkt Cap
272.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18AugExpected
Expected EPS
-0.445
Actual EPS
N/A
Financials
-365.6%Profit Margin
Unprofitable10.35MRevenue
-37.83MNet Income
Analyst Ratings
15.00Average Price Target
The highest estimate is 15.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ARMP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform. Within its product pipeline are several significant candidates: AP-SA02, designed for the treatment of Staphylococcus aureus bacteremia; AP-PA02, targeting Pseudomonas aeruginosa; and AP-PA03, intended to address pneumonia. Additionally, Armata has forged a collaborative agreement with Merck & Co. to further the development of synthetic bacteriophage candidates aimed at specific, yet unrevealed, infectious disease agents. The company's main offices are located in Marina del Rey, California.
Show more...
CEO
Dr. Deborah L. Birx M.D.
Employees
60
Country
United States
ISIN
US04216R1023
Listings
0 Comments
Share your thoughts
FAQ
What is Armata Pharmaceuticals stock price today?▼
The current price of ARMP is $7.51 USD — it has increased by +2.32% in the past 24 hours. Watch Armata Pharmaceuticals stock price performance more closely on the chart.
What is Armata Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Armata Pharmaceuticals stocks are traded under the ticker ARMP.
Is Armata Pharmaceuticals stock price growing?▼
ARMP stock has risen by +0.2% compared to the previous week, the month change is a -5.77% fall, over the last year Armata Pharmaceuticals has showed a +301.6% increase.
What is Armata Pharmaceuticals market cap?▼
Today Armata Pharmaceuticals has the market capitalization of 272.84M
When is the next Armata Pharmaceuticals earnings date?▼
Armata Pharmaceuticals is going to release the next earnings report on August 18, 2026.
What were Armata Pharmaceuticals earnings last quarter?▼
ARMP earnings for the last quarter are -3.16 USD per share, whereas the estimation was -0.38 USD resulting in a -731.58% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Armata Pharmaceuticals revenue for the last year?▼
Armata Pharmaceuticals revenue for the last year amounts to 10.35M USD.
What is Armata Pharmaceuticals net income for the last year?▼
ARMP net income for the last year is -37.83M USD.
How many employees does Armata Pharmaceuticals have?▼
As of June 15, 2026, the company has 60 employees.
In which sector is Armata Pharmaceuticals located?▼
Armata Pharmaceuticals operates in the Health & Wellness sector.
When did Armata Pharmaceuticals complete a stock split?▼
The last stock split for Armata Pharmaceuticals was on May 10, 2019 with a ratio of 1:14.
Where is Armata Pharmaceuticals headquartered?▼
Armata Pharmaceuticals is headquartered in Los Angeles, United States.